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Individuals may show different responses to stressful events. Here, we investigate the neu-
robiological basis of stress resilience, by showing that neural responsitivity of the nora-
drenergic locus coeruleus (LC-NE) and associated pupil responses are related to the
subsequent change in measures of anxiety and depression in response to prolonged real-life
stress. We acquired fMRI and pupillometry data during an emotional-conflict task in medical
residents before they underwent stressful emergency-room internships known to be a risk
factor for anxiety and depression. The LC-NE conflict response and its functional coupling
with the amygdala was associated with stress-related symptom changes in response to the
internship. A similar relationship was found for pupil-dilation, a potential marker of LC-NE
firing. Our results provide insights into the noradrenergic basis of conflict generation,
adaptation and stress resilience.
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Mental disorders are a major source of cost and societalburden worldwide, and the prevalence of such disordersis on the rise1,2. A decisive contributing factor is the
increased level of acute stress inherent to society3,4, particularly in
the work place5. Even though exposure to prolonged stress or
potentially traumatic events generally increases vulnerability to
psychopathology, individuals vary considerably in how they
respond to such stressors4. The majority of individuals exhibit
resilient responding without any psychological problems or only
minimal, transitory reductions in everyday functioning. Others,
however, exhibit substantial stress-related psychopathology
comprising anxiety and depression symptoms4,6–9. Despite great
interest in advancing our mechanistic understanding of stress-
related psychopathology10, the biological basis for human stress
resilience and its heterogeneity remains largely unknown. Here
we highlight a neurobiological mechanism associated with stress
resilience in humans and may therefore help to improve pre-
diction and treatment of stress-related psychopathology.
Decades of invasive animal neurophysiology have associated the
vulnerability to prolonged stress with a hyper-responsivity of the
locus coeruleus, the noradrenergic (LC-NE) arousal system11–15.
The LC-NE is a small pontine nucleus that sends numerous
projections throughout the entire central nervous system16,17 and
plays a vital role in the central stress circuitry18–22. The LC-NE is
ideally suited for upregulating various physiological processes that
mobilize energy and promote autonomic adaptation in response
to stress23–27. Critically, sustained stress responses associated with
LC-NE hyper-responsivity have been shown to contribute to
chronic anxiety and depression, fear, posttraumatic stress disorder
(PTSD), increased risk of hypertension, and cardiovascular
disease28–35. Moreover, recent reports suggest that the functional
coupling of noradrenergic projections between the locus coeruleus
and amygdala—a region associated with the amount of emotional
intensity, fear and threat perception in humans36–39—promote
stress-induced anxiety-like behavior in mice30,40. In humans,
however, a lot less is known about the relationship between LC-
NE hyper-responsivity and stress vulnerability. Even though
heightened LC-NE activity has been observed in patients with
anxiety, depression, and PTSD41–46, the majority of human stu-
dies has for ethical reasons only been able to investigate brain
activity accompanying stress-related symptoms after severe stres-
sors had been encountered46–48. Such studies essentially measure a
system already perturbed by stress; they thereby can neither
identify the brain mechanisms that predispose an individual to be
vulnerable to stress nor help us predict who will succumb to stress
and who will be resilient. The current gold standard for psycho-
pathology predictions consists of standardized verbal surveys, but
these can be unreliable due to self-report bias and other factors49.
Evidently, there is a clear need for truly prospective studies linking
individual characteristics of the human LC-NE system to the
severity of psychopathology subsequently induced by real-life
stressors10,11,50–52.
Here, we measured individual LC-NE responsivity in a
laboratory task and use this to predict the degree by which par-
ticipants are affected by future stress in the real world. We
addressed this question by acquiring behavioral measures, pupil-
dilation (an external marker associated with noradrenergic LC-
NE firing53 and cholinergic activity54), and fMRI data of LC-NE
responses as well as functional coupling between LC-NE and
amygdala30,40. This allowed us to identify which of these markers
is associated with changes in stress-related symptomatology,
thereby helping us to understand the neural mechanisms of
stress-related psychopathology and inform future intervention
and treatment methods10,11,50–52.
To assess the responsivity of the LC-NE system inside the
MR scanner, we employed the emotional-Stroop task36,55,56, a
well-established laboratory measure of affective conflict57,58.
Affective conflict in this task serves as a model for conflicts that
people have to resolve in emotionally charged situations that are
often perceived as real-life stressors58,59. Considerable evidence
suggests that such conflict-related signals engage the arousal
system in monkeys and humans. For instance, conflict signals in
the macaque brain, induced via task-congruent and -incon-
gruent stimuli of monkey faces, predicted subsequent changes in
pupil size and reduced behavioral distractor interference60,61.
These data are consistent with the hypothesis that pupil-linked
arousal mechanisms regulate conflict adjustments in non-
human primates60,61. Moreover, several prior human func-
tional imaging reports show reliable involvement of LC-NE
system during conflict resolution involving stroop-tasks62–64 as
well as during tasks requiring the resolution of unexpected
uncertainty65. We chose the conflict task over another standard
task reported to activate the arousal system, the odd-ball task66,
because a previous report indicated no correlation between
human LC-odd-ball-responses and any additional physiological
measure such as pupil-dilation, skin-conductance or heart-
rate46. Critically, this study also did not find any association
between the odd-ball induced LC-NE response and the severity
of anxiety or depression symptoms, which are the focus of the
present work.
In the emotional-Stroop task we employed, participants cate-
gorized faces according to their emotional expression (happy vs.
fearful), while at the same time ignoring overlayed emotionally
congruent (C) or incongruent (I) words (“HAPPY”, “FEAR”,
Fig. 1a). In this task, conflict arises from an emotional incom-
patibility between task-relevant and task-irrelevant stimulus
dimensions. The resolution of conflict incurs processing costs,
including an upregulation of task-relevant information67, which
have been associated with increased arousal and noradrenalin
release thought to involve the LC-NE68–72. Behaviorally, the
conflict is typically observed as higher reaction times (RT) for
incongruent than congruent trials36,55,73 and as congruency-
sequence effects73,74 (Fig. 1b): responses in conflict-inducing
incongruent trials are faster when the previous trial was also
incongruent (II), compared to when the previous trial was con-
gruent (CI), reflecting time-consuming noradrenergic upregula-
tion processes necessary when conflict is encountered after no-
conflict trials68,69. These upregulation processes have lasting
effects and therefore carry over to the subsequent incongruent
stimulus on II trials36,55,73,75. We thus contrasted CI > II trials
(which are identical in terms of presented stimuli and response
requirements) to isolate neural processes involved in potentially
noradrenergic69–72 upregulation of cognitive control. This con-
trast essentially provides us with a measure of how much an
individual brain is taxed by upregulation to resolve emotional
conflict. We indexed the effects of this contrast on basic LC-NE
activation, the downstream consequence of functional coupling
between LC-NE and amygdala, and the peripheral LC-NE-related
pupil dilation70–72. Using these measures, we could thus test
whether higher responsivity of human LC-NE before the onset of
a real-world stressor may predict the degree to which an indivi-
dual will be affected by this stressor.
To accomplish this, we used a prospective design in a sample of
medical students prior to their first medical internship. Medical
students constitute a typical at-risk population: They have
recently been identified as being alarmingly vulnerable to stress-
related disorders76,77, presumably due to ample exposure to sig-
nificant stress and adversity during their medical internships78,79.
We indexed levels of depression and anxiety at three time points:
Prior to the internship (at the same time as fMRI and pupillo-
metry) as well as 3 and 6 months later during the internship. This
repeated clinical assessment protocol allowed us to account for
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initial individual baseline levels of distress prior to the real-world
stressor and to fully capture expected variability in stress resi-
lience amongst participants4,80. We quantified the utility of our
biomarkers by comparing their predictive accuracy to that of
subjective reports and ensured external validity by cross-
validating our predictions81.
Results
Conflict-induced upregulation involves LC-NE. We first estab-
lished that our paradigm was indeed suitable by fully replicating
previous behavioral and neural effects of conflict and trial
sequence36,82,83 (Supplemental Figures S1, see the Supplemental
Information for comprehensive results, figures, and tables). Most
Fig. 1 Experimental task and neural conflict-induced upregulation responses (CI > II). a Example stimuli illustrating all four possible face/word
combinations in the emotional-stroop task. Face stimuli used in our experiment were identical to the face stimuli used in Etkin et al. 2006. For illustrative
purposes, we have replaced these images here with open access face stimuli (https://faces.mpdl.mpg.de/imeji/). Participants were instructed to react to
the facial expression while ignoring the overlaid word and to answer as fast and accurately as possible. On each trial, the word color was randomly assigned
in order to avoid adaptation effects. b Trial presentation schedule. A CI-trial is an incongruent trial preceded by a congruent trial. An II-trial is an
incongruent trial preceded by an incongruent trial. Subtracting neural responses for II from CI trials reveals regions involved in the upregulation response
(CI > II), while subtracting neural responses for CI from II trials reveals regions associated with implicit conflict adaptation (II > CI). See Supplemental
Methods for details on stimulus presentation and counterbalancing of conditions. c Cortical and subcortical regions involved in generating an upregulation
response to resolve conflict. Mid-saggital slice with activation clusters shows higher activity to incongruent trials preceded by a congruent trial (CI) as
compared to incongruent trials preceded by an incongruent trial (II) (left superior temporal cortex (STC), posterior cingulate cortex (PCC), anterior visual
cortex and a large subcortical cluster, FWE-cluster-correction at p= 0.05 with cluster-forming-threshold at p= 0.001, One-sample t test, one-sided, the
pseudo-color-map illustrating the one-sample t statistic applies to all panels). Inset shows magnified lateral-view of subcortical cluster and an overlaid
locus coeruleus mask in green (2SD-mask from Keren et al.88). d Coronal view of standard brain and magnified view of bilateral LC upregulation response
(hot colors) overlaid with LC mask (green). e Participants (N= 48) with high subsequent anxiety/depression symptom changes show significantly
stronger LC-NE responsivity (CI > II) than participants with lower symptom changes (median split), two-sample t test, two-sided, anxiety: p= 0.019; T=
2.431, depression: p= 0.037; T= 2.154. Bar plots show the LC-responsivity strength extracted from the CI > II contrast in the physiological noise
controlled, unsmoothed data as weighted-average of LC-1SD mask voxels (see Supplemental Fig. S8 for detailed statistics and comparison with LC-2SD
mask voxels). Single dots show individual data. Errorbars represent ±SEM. *p < 0.05. Source data are provided as a Source Data file.
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importantly for our present purpose are the so-called trial-
sequence effects: When a conflict trial is preceded by a no-conflict
trial (CI), the brain needs to mobilize and upregulate resources on
the current trial in order to meet these response conflict chal-
lenges. The effects of this mobilization are thought to persist and
affect the next trial, leading to less conflict for subsequent conflict
trials (II). Thus by contrasting neural activity (CI > II), we isolated
the effects of individual LC-NE upregulation in the presence of
identical stimuli and motor demands. In line with our predic-
tions, the locus coeruleus was strongly recruited during conflict-
induced upregulation. Contrasting CI > II trials (Fig. 1c–e)
revealed robust activity in the midbrain/brainstem (cluster extent
= 170, degrees of freedom (df)= 47, non-parametric P(FWE)=
0.039, X/Y/Z: 6/-27/-10, Fig. 1). A region-of-interest analysis
in the locus coeruleus revealed significant CI > II responses,
confirming a role of the subcortical noradrenergic arousal system
in the conflict response (LC-Right: non-parametric P(SVC)=
0.003, X/Y/Z: 6/-37/-28, Fig. 1c–e and Supplemental Table S1).
Other brain areas previously reported for this contrast (such as
amygdala and DLPFC)36,55,84 were also replicated here (Supple-
mental Fig. S2 and Supplemental Table S1; see also Supplemental
Fig. S3 for replications of regions identified with the reverse
contrast II > CI).
Real-world stress exposure is associated with elevated anxiety
and depression symptoms. To predict individual resilience to
real-wold-stress, we acquired our physiological laboratory mea-
sures as well as initial baseline anxiety and depression scores in
the week prior to the onset of a stressful medical internship
(timepoint T0). To quantify the symptom-severity change from
baseline level, we obtained additional anxiety and depression
scores at 3 months (T1) and 6 months (T2), please see Methods
for details. As expected, group-level symptom severity for both
psychological test scores increased over time due to the stressful
medical internship (the main effect of time for anxiety, F= 4.01,
p= 0.022 and depression, F= 3.11, p= 0.049; repeated-measures
ANOVA, controlling for gender and age, degrees of freedom=2).
Post-hoc t tests further identified symptom increases at 3 and
6 months relative to baseline level, albeit not always significantly
(Fig. 2) (Depression: 3 months: T(1,47)= 1.83, p= 0.037,
6 months: T(1,47)= 1.75, p= 0.0448, mean-change: T(1,47)= 2.00,
p= 0.025, Anxiety: 3 months: T(1,47)= 1.62, p= 0.056, 6 months:
T(1,47)= 0.917, p= 0.182, mean-change: T(1,47)= 1.44, p= 0.078,
one-sample t test, one-sided). The observed symptom changes are
smaller than those reported in a previous study involving the
American medical system79, suggesting comparably milder levels
of stress in the current Swiss cohort. Most importantly, however,
we observed substantial interindividual variability in these
symptom changes (see the individual symptom profiles in Fig. 2),
confirming the individual differences in susceptibility to stress
required for our predictive approach. Please note that we did not
aim to predict whether or not a participant develops stress-related
symptoms above a clinically relevant cut-off. However, see the
Supplemental Information for quantification of effect sizes,
demographic information, participant counts reaching clinically
relevant cut-offs, and the relationship of symptom severity
changes to non-prospective measures such as adverse events
experienced during the internship (Supplemental Tables S2–S5
and supplemental section: adverse events during internship).
Optimizing brainstem signals. Optimal functional imaging of
the brainstem, and in particular the LC, is notoriously difficult
due to the small size of the nuclei involved, their proximity to the
ventricles, and inherently low signal-to-noise ratio in the brain-
stem. In order to unequivocally identify LC-NE activity, non-
standard techniques would be ideal for both data acquisition and
analysis85–87 On the acquisition side this would, for instance,
entail high-field imaging and partial-brain coverage, which allows
particularly small (submillimeter) voxel resolution to avoid partial
voluming and reduce pulsating artefacts from the adjacent 4th
Fig. 2 Symptom severity scores and severity changes across time. a Anxiety symptom severity prior to and after 3 and 6 months of medical internship.
b Anxiety symptom severity changes relative to initial anxiety baseline level prior to the internship (time of imaging experiment). One-sample t test, one-
sided. c Depression-symptom severity prior and after 3 and 6 months of medical internship. d Depression-symptom severity changes relative to initial
depression baseline level prior to the internship. Each dot (and their connections) represents data (and changes) for a single subject (N= 48). Top and
bottom of boxes indicate 75th and 25th percentile of the underlying distribution respectively. Horizontal lines within boxes indicate the mean (black) and
median (dotted). One-sample t test, one-sided. Source data are provided as a Source Data file.
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ventricle (please see the limitations section for a discussion of
fundamental methodological steps to improve brainstem ima-
ging). However, the use of such a specialized imaging protocol
would preclude whole-brain imaging and therefore inferences
about influences of the LC on other brain systems (e.g., the
amygdala and neocortical areas involved in conflict processing).
Moreover, it would make it difficult for our approach to be
replicated and extended in standard fMRI lab settings around the
world. Thus, we opted for a standard 3T scanner and a routine
fMRI-sequence with relatively low voxel resolution (2.5 mm iso-
tropic) that nevertheless retains good signal-to-noise ratio in the
brainstem (Supplemental Figs. S4–S6). Importantly, to ascertain
the specificity of our results to the LC, we conducted multiple
mutually corroborating analyses. These included weighted aver-
aging for data extraction from brainstem regions of interest,
control for additional brainstem nuclei, controlling for physio-
logical nuisance variables based on principle component analysis
of individually identified CSF probability tissue classes, as well as
applying these nuisance variables in additional regression models
to both smoothed and unsmoothed data. Please see the methods
and supplementary methods section for detailed descriptions of
these techniques, additional figures (S4–S7) and statistical results
tables (Tables S4 and S6), as well as a formal temporal-signal-to-
noise (tSNR) analysis of the whole brain and specifically the
brainstem. Given all these methodical procedures, and the spe-
cificity of our results, the signals we extracted can be cautiously
attributed to the LC despite our use of a more standard imaging
protocol.
LC-NE responsivity is associated with stress-related anxiety
and depression symptom change. To demonstrate that the LC is
indeed reliably related to the CI > II contrast, while at the same
time taking individual differences in LC conflict responsivity into
account, we split the sample into participants who went on to
develop stronger vs weaker mean anxiety/depression symptoms
(median split). This allowed us to analyze LC responses (the
weighted average LC-1SD extracted, physio-corrected, unsmoothed
fMRI data) to our conflict task in people with high versus low
susceptibility to develop psychopathology in response to stress.
Given our hypothesis—derived from rodent studies—that hyper-
responsivity of the LC-NE predisposes vulnerability to prolonged
stress exposure, we expect participants with high symptom severity
changes to also show high LC responsivity, while participants that
exhibit less or no changes in symptom severity are expected to
show low LC responsivity. Indeed, we found that participants with
high symptom severity changes exhibited significant LC-NE
responsivity (CI > II) that was significantly stronger than the cor-
responding effect in participants with low symptom severity
changes (Fig. 1e). These effects were similarly present for both
symptom types (Anxiety: high symptom changes group: df= 22,
T= 2.437; p= 0.023; low symptom changes group: df= 24, T=
−0.895; p= 0.379; high vs. low symptom changes groups: df= 46;
T= 2.431; p= 0.019; Depression: high symptom changes group:
df= 20; T= 2.21; p= 0.039; low symptom changes group: df= 26;
T=−0.611; p= 0.546; high vs. low symptom changes groups:
df= 46; T= 2.154; p= 0.037) and types of LC-NE mask choice
(see Figure S8 for comparison between masks). Thus, the results of
this analysis suggest that the LC is involved in response conflict
adaptation, specifically for people who go on to develop stronger
subsequent psychopathological symptoms. This validates our
measure and suggests that it may be useful for predicting the
development of stress-related psychopathology.
To formally establish this predictive validity of conflict-induced
LC-NE responsivity for stress resilience, we correlated the
participants’ symptom severity changes at 3 and 6 months (Fig. 2)
with their individual fMRI-BOLD-amplitude during conflict-
induced upregulation (CI > II) in the locus coeruleus (extracted
from physiological noise corrected, unsmoothed data with
weighted averaging across voxels in the LC-1SD-mask88).
Individual LC-NE responsivity indeed correlated significantly
with anxiety- and depression score changes measured three and
six months into the internship as well as with the mean symptom
changes across 3 and 6 months (df= 47, t1, anxiety: Rho= 0.30,
p= 0.018, depression: Rho= 0.38, p= 0.004, t2, anxiety: Rho=
0.31, p= 0.002, depression: Rho= 0. 26, p= 0.034; mean between
t1 and t2, anxiety: Rho= 0.30, p= 0.002, depression: Rho= 0.36,
p= 0.006, non-parametric Spearman’s rank correlation coeffi-
cient and robust regression, Fig. 3a–f). That is, smaller conflict
responses in the LC-NE system to the CI > II contrast were
associated with less anxiety and depression symptom change, and
thus more resilience, during the subsequent internship89.
To ensure predictive relevance and local specificity for the
locus coeruleus, we compared symptom change predictions for
anxiety and depression between analyses employing two types of
LC masks (1SD and 2SD), as well as for analyses based on activity
extracted from several other brainstem nuclei in the vicinity of
the LC, i.e.: medial raphe nucleus (MR), dorsal raphe nucleus
(DR), and ventral tegmental area (VTA)89. We also compared the
predictive power of LC signals with that of signals extracted from
the substantia nigra (SN), and the amygdala (please see
supplemental methods details and Supplemental Figure S6 for a
visualization of these brainstem structures). In addition, we tested
whether these predictions hold for LC-extracted weighted
averages from different analysis pipelines with or without spatial
smoothing and physiological noise correction, respectively.
The additional results reveal that stress-related anxiety and
depression symptom changes were most strongly associatd with
the locus coeruleus, compared to all other brainstem nuclei. They
also underline the robustness of our results in several ways. For
example, the choice of LC mask did not bias the results: The LC
was the only structure associated with symptom changes, for both
available types of standardized LC masks (1SD & 2SD; the smaller
and more robust mask (1SD) yields the stronger correlations).
Physio-correction generally improved the statistics in nuclei
closest to the 4th ventricle, such as the LC, medial raphe, and
dorsal raphe (in fact, in the physio-corrected smoothed data, DR
and MR correlate with symptom changes as well). However, the
physio-corrected unsmoothed data (as reported in detail above
and illustrated in Fig. 3a–f) showed that the LC was the only
region associated with both anxiety and depression changes,
irrespective of LC-mask choice, suggesting that DR and MR
correlations in the smoothed data may stem from a smearing of
LC activity into these neighboring regions. These additional
analyses further strengthen our main conclusion that stress
resilience is associated with responsivity of the LC. We
summarize the results of all these analyses in the Supplemental
Table S6 (also see Supplemental Figure S4–S8 illustrating our
additional analyses).
We also conducted a formal analysis of the temporal signal-to-
noise ratio (tSNR) across the whole brain, and in particular in the
brainstem, making it easier to assess the signal quality of the
extracted LC signals in comparison with other brainstem
structures. The tSNR was computed by dividing the mean of
each time series by its standard deviation for each voxel in the
brain. The results confirmed that both the average and subject-
specific tSNR in the LC was well above standard cut-offs (>30).
We also found that the signal in the LC was in fact strongest
amongst all brainstem nuclei, for both standard LC masks (1SD &
2SD, see Supplemental Figs. S4–S6).
Next, we formally tested the predictive validity of the individual
LC-NE upregulation response for symptom changes in the
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population. We first compared the observed symptom severity
change with the predicted change score in an out-of-sample
fashion. To do so, we estimated a linear regression of psychological
test score data on neural CI > II responses (weighted average LC-
1SD extracted, physio-corrected, unsmoothed data) for the data of
all participants excluding the current participant90–92 and then
used this fitted model to predict for the left-out participant the
individual mean change in symptom severity. For simplicity, we
focus on the mean symptom changes (mean across 3 and
6 months) in the remainder of the manuscript. A significant
correlation in this out-of-sample procedure indicates that across
the population, LC-NE responsivity can reliably predict individual
stress resilience in the future93. We did observe such predictive
validity: For both anxiety and depression, predicted symptom
severity changes correlated with the observed symptom changes
(df= 47, anxiety: Rho= 0.25, p= 0.01, depression: Rho= 0.28, p
= 0.05, non-parametric Spearman’s rank correlation coefficient
and robust regression, Fig. 4a, c).
As a second step, we tested whether we can predict from the
measure of LC-NE responsivity (weighted average LC-1SD
extracted, physio-corrected, unsmoothed data) which out of two
randomly chosen participants will be more resilient, i.e., incur a
smaller symptom change after experiencing real-world stress. A
leave-two-subjects out procedure (LTSO, see Methods) showed
that the individual LC-NE upregulation response predicts above
chance which subject developed higher anxiety symptom change
(prediction accuracy 60.3%, p < 0.001, Fig. 4b). Similarly, LC-NE
upregulation responses also predicted above chance which
subjects developed higher depression symptom change due
to real-life stress (prediction accuracy 59.4, p < 0.001, Fig. 4d).
To compare between anxiety and depression predictions, and to
compare the predictive validity of different resilience predictors,
we provide the receiver-operator characteristic curves (ROCs)
and the associated area under the curve (AUC) plots (see below).
To establish the specificity of the LC-NE response for
predicting symptom severity changes, we also tested other regions
identified with the CI > II contrast such as the amygdala, dmPFC,
vmPFC, and dlPFC. These regions (please see Supplemental
Figure S9) either did not correlate at all with symptom changes
(dmPFC, amygdala) or only for single time points or symptoms
(3 months: vmPFC, anxiety: p= 0.048, depression: p= 0.023;
depression at 3 months: dlPFC, p= 0.003). Moreover, to test the
specificity of the upregulation response (CI > II) in predicting
stress resilience, we explored whether conflict adaptation (II > CI)
or mere conflict processing (I > C) responses in the LC revealed
any significant correlations with symptom severity changes.
Neither contrast revealed any significant cluster (all p > 0.05
FWE-corrected). Finally, no other regions of interest identified
with these contrasts revealed any significantly correlation with
symptom severity change (II > CI; left dlPFC or SMA, I > C;
dmPFC, all p > 0.05, Supplemental Figure S10). This confirms the
specificity of the LC-NE upregulation response as a biomarker for
predicting future stress resilience in our sample (and comparable
populations undergoing similar stressors).
LC-NE amygdala functional coupling during upregulation is
related to symptom changes. Recent evidence from mouse models
suggests that anxiety-like behavior is promoted by noradrenergic
projections from the locus coeruleus to the amygdala30,40. We thus
tested whether functional coupling between LC-NE and the
amygdala during the upregulation response (CI > II) also relates to
Fig. 3 LC-NE responsivity (CI > II) relates to increases in anxiety and depression due to prolonged real-world stress exposure. Each panel visualizes the
correlation (robust linear regressions) between participants’ symptom severity and individual CI > II responses, extracted from physiological-noise-
corrected, unsmoothed data with weighted averaging across voxels in the LC-1SD-mask. Please note that the symptom severity used for these correlations
is defined as the change from the individual symptoms baseline level at measurement time t0. a–c Correlation between LC responsivity (CI > II) and
severity of anxiety symptom changes (STAI) (top) measured after 3 months (a) and 6 months (b) of exposure to real-world chronic stress as well as the
mean change between both measurement time points (c). d–f Same as (a–c), but for severity of depression symptoms change (PHQ). Source data are
provided as a Source Data file.
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anxiety and even depression changes in humans. In a psychophy-
siological interaction analysis (PPI, Methods), an a priori region-of-
interest in the amygdala showed functional coupling with the LC-
NE during the upregulation response (CI > II), and the strength of
this coupling correlated with the mean symptom severity changes
for both anxiety and depression (df= 47, anxiety: P(SVC) < 0.001,
X/Y/Z: -25/1/-23, T= 6.72, Z= 5.58; depression: P(SVC) < 0.001,
X/Y/Z: 31/-2/-18, T= 3.45, Z= 3.24; Fig. 5). Note that correlations
with symptom changes after either 3 or 6 months yields comparable
results (please see Supplemental Figure S11, also for additional
regions from exploratory whole-brain analysis), but we focus on the
relationship with mean symptom changes for simplicity. This
relationship was again specific to upgregulation (CI > II), since the
same analyses for conflict adaptation (II > CI) did not reveal a
correlation with symptom severity change for LC-NE coupling with
the amygdala (p > 0.05, small-volume-corrected) or other brain
regions (p > 0.001, uncorrected). Likewise, no significant differences
were observed when we analyzed coupling of LC-NE with the
amygdala or other brain regions for differences between I > C trials
or II > CI trials. Tests of predictive validity in the population (LTSO,
see “Methods”) again revealed that the individual LC-NE amygdala
functional coupling during conflict response predicted above
chance which of two new subjects developed stronger changes in
anxiety (56.3%, p= 0.002) and depression (56.0%, p < 0.001)
symptoms as a consequence of the real-life stressor (Fig. 5g, h).
Our results thus extend prior work in rodents showing that the
functional coupling between LC-NE and amygdala is directly
related to levels of fear and anxiety30,40. Given the well-known
association of the amygdala with the perception of emotional
intensity, fear, and threat in humans36–39, our data may suggest
that a pathological hyper-reactivity of noradrenergic LC-NE may
enhance amygdala activity; this in turn may lead to elevated levels
of fear and anxiety and eventually to stress-related psychpathol-
ogy. Irrespective of this speculation, our data indicate that
functional coupling of LC-NE with the amygdala during
upregulation processes is a biomarker for predicting stress
resilience, particularly with respect to anxiety symptoms To
compare between anxiety and depression predictions, and to
compare the predictive validity of different resilience predictors,
Fig. 4 Out-of-sample prediction of mean symptom severity changes.
a Correlation between out-of-sample predicted and observed mean anxiety
symptom severity changes due to emergency room internship stress.
Robust linear regressions. b LC-NE upregulation responses predict
significantly above chance which of two subjects left out of the estimation
will show stronger mean anxiety increases as a consequence of stress.
Prediction analyses were based on a leave-two-subjects-out cross-
validation procedure; their significance was tested using a permutation test
with 1000 permutations for each possible left-out pair combination.
Dashed lines indicate the 5th and 95th percentile of the randomized labels
distribution, respectively. Thick black vertical line indicates the obtained
prediction accuracy. (c, d) as in (a, b) but for depression symptom changes.
Please see “Methods” section for details. Source data are provided as a
Source Data file.
Fig. 5 Functional coupling between LC-NE and amygdala during
upregulation response relates to symptom changes. Functional coupling
between LC-NE and amygdala during the conflict response relates to
individual changes in symptom severity for mean anxiety (a, c) and
depression (b, d). e LC-NE-amygdala functional coupling (PPI: CI > II
contrast betas extracted within bilateral amygdala mask using LOSO, see
“Methods”) relates to mean anxiety-symptom changes (R= 0.62, simple-
regression: p < 0.001, robust regression, p= 0.052) and (f) mean
depression-symptom changes (R= 0.34, simple-regression: p= 0.019,
robust regression, p= 0.020). Mean symptom changes were defined as
the mean between changes after 3 and 6 months. g LC-NE-amygdala
functional coupling during upregulation response (extracted with LOSO)
predicts mean anxiety symptom severity change above chance (p= 0.002,
prediction accuracy 56.3%). h Similarly, for depression (p < 0.001,
prediction accuracy 56.0%). Prediction analyses were based on a leave-
two-subject-out cross-validation procedure; their significance was tested
using a permutation test with 1000 permutations for each possible left out
pair combination. Source data are provided as a Source Data file.
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we provide ROC and the associated AUC plots (see below and
Supplemental Figs. S12–S14).
Conflict response and noradrenergic upregulation is reflected
in pupil dilation. Given the hypothesized link between pupil
dilation and noradrenergic LC-NE firing16,53,66, we investigated
how pupil dilation related to emotional conflict responding and
upregulation, and whether this index is useful for predicting stress
resilience. An increasing number of studies have employed pupil
dilation as an index of activity in the LC-NE system94–98, and
conflict-related pupil dilation has been observed in the classic
Stroop task99–102. Here we extend these results to the emotional
Stroop task: We found significantly enhanced pupil dilation for
incongruent trials compared to congruent trials between 945 ms
and 3668ms post-stimulus onset (p < 0.05, one-sample t test,
corrected for multiple comparisons using cluster-based permu-
tation test89, two-sided, df= 47, Fig. 6a, b, supplemental meth-
ods), demonstrating that the LC-NE contribution to conflict
processing observed with fMRI is indeed also reflected in the
pupil101–103. In keeping with our imaging analysis, we also
observed trial sequence effects (CI > II) in the pupil signal:
Pupil dilation for II trials yielded significantly enhanced pre-trial
pupil dilation as compared to CI trials, between −3044 ms and
−1222 ms prior trial onset (p < 0.05, one-sample t test, cluster-
corrected, Fig. 6c). Interestingly, between 1530 and 4862 ms post-
trial onset, we observed the opposite pattern of substantially lower
pupil dilation for II compared to CI (p < 0.05, one-sample t test,
cluster-corrected, Fig. 6d). These findings clearly indicate a
(potentially noradrenergic) carry-over effect from previous- to
current-conflict trials: Pupil signal was reduced on incongruent
trials when these were preceded by an incongruent trial. These
peripheral-physiological results further strengthen the evidence
for the role of a putative noradrenergic mechanism in the conflict
response and potentially in conflict adaptation.
Pupil dilation and constriction are typically observed in
response to changes in ambient lighting. This well-documented
light reflex response was reported to be driven by parasympa-
thetic activity and opposes the influences of sympathetic arousal
on the pupil104–106. We verified that conflict-related trial history
effects on the pupil signal were not simply reflections of ambient
light level differences between preceeding congruent and incon-
gruent conditions. For this, we analyzed congruency effects on
congruent trials without any conflict, during which any pupil
differences would be attributed to differences in visual stimula-
tion between preceeding trials (IC > CC, Fig. 6e,f). No significant
pupil dilation differences were observed (p > 0.05, cluster-
corrected), confirming that light reflex responses cannot explain
the congruency-sequence effects in our pupil data.
Pupil-related conflict response relates to LC responsivity and
stress resilience. Congruency-sequence effects in conflict tasks
usually show that interference on a given trial is reduced if it is
preceeded by a conflict trial. Mechanistic interpretations of this
effect suggest that conflict situations (such as incongruent sti-
muli) lead to arousal and noradrenalin release, facilitating conflict
processing and resolution on the subsequent trial due to carry-
over effects68,73. Such an account predicts that the strength of LC-
NE activation on the preceeding incongruent trial should be
inversely related to the LC-NE activity on the current incongruent
trial, and reflected in pupil and in LC-BOLD responses. Both
predictions were verified with our data: The increase in pre-trial
pupil dilation for CI relative to II trials was negatively correlated
with the subsequently-measured, stimulus-related CI > II pupil
dilation difference (df= 47, p= 0.00014, R=−0.52, Fig. 7a)
and the CI > II difference in LC-NE BOLD responses (df= 47,
p= 0.038, R=−0.30, Fig. 7b). To capture these trial-sequence
effects in one pupil measure and relate it to individual symptom
severity changes, we computed the pupil dilation distance (PDD)
between current trial CI > II minus pre-trial CI > II and related it
to mean anxiety and depression symptom severity changes. Even
though we found a significant correlation between PDD and
mean anxiety symptom changes (p= 0.013, R= 0.36), the out-of-
sample predictions did not exceed chance level (p= 0.09, 52.6%).
However, mean depression symptom changes were related to
PDD (p= 0.04, R= 0.30) and also predicted out-of-sample above
chance (p < 0.001, 55.3%). This suggests that pupil dilation
measures alone can already be useful for predicting depression-
related resilience in response to subsequent real-life stressors To
compare between anxiety and depression predictions, and to
Fig. 6 Pupil dilation during response conflict (I > C) and upregulation (CI
> II). a Mean Pupil dilation during congruent (green) and incongruent trials
(red). b Pupil dilation during incongruent trials is significantly larger as
compared to congruent trials. Gray shades area indicates sign. difference
p < 0.05 (One-sample t test, two-sided, cluster-corrected). Vertical line
indicates stimulus onset. c Mean Pupil dilation during CI trials (incongruent
trials preceded by congruent trials = dark red) and II trials (incongruent
trials preceded by incongruent trials = light orange). d II trials yield
significantly enhanced pre-trial pupil dilation as compared to CI trials,
indicating the need for noradrenergic upregulation on current CI trials. The
gray shaded area indicates significant difference from zero at p < 0.05,
(One-sample t test, two-sided, cluster-corrected). Vertical line indicates
stimulus onset. e Mean Pupil dilation during CC trials (congruent trials
preceded by congruent trials = light green) and IC trials (congruent trials
preceded by incongruent trials = dark green). f Pupil dilation for CC trials
does not significantly differ from IC trials before or during the current
congruent trial, precluding potential light reflex differences (see main text).
Error bands represent ±SEM at each timepoint. Source data are provided as
a Source Data file.
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compare the predictive validity of different resilience predictors,
please see the ROCs and the associated AUC plots in Figs. 8, 9 as
well as Supplemental Figs. S12–S14.
Locus Coeruleus responsivity is a robust and reliable bio-
marker for stress resilience. In a final analysis, we quantified and
compared the usefulness of the identified biomarkers for pre-
dicting stress resilience by first comparing their predictive validity
to that of a base-model (the current gold standard: self-report
surveys of previous potentially traumatic experiences or current
symptoms) using a multiple GLM-approach. We also identified
the most parsimonious parameter combinations for predicting
individual anxiety or depression symptom change, by means of a
stepwise-regression approach (Methods; for a comprehensive list
of parameter test-statistics, goodness-of-fit measures, and model
comparisons please see Supplemental Tables S7 and S8). Finally,
we compared the out-of-sample prediction accuracy between the
base model, full model (containing all parameters), and most
parsimonious model using LTSO (Methods). Please note that the
LC-specific regressor was extracted using the weighted average
LC-1SD mask from the physio-corrected, unsmoothed fMRI data
(Tables S7 and S8). For completeness, Supplemental Tables S9,
S10 report the full list of statistics for data without these
corrections.
These analyses showed that our identified biomarkers sub-
stantially improved predictions of anxiety symptom changes as
compared to the gold-standard base-model. The adjusted
explained variance was increased by 400 and 300%, respectively,
when we added either LC (p= 0.017) or pupil (p= 0.039) to the
regression. The classic behavioral congruency-sequence effect
(CSE) was neither significant on its own (p > 0.1, model 2) nor in
models containing either LC (model 3) or pupil (model 4).
Having both LC and pupil regressors in one model explaining
anxiety changes (model 5) further increased the explained
adjusted variance (by about 20%); this model established LC (p
= 0.02) and pupil (p= 0.04) as reliable predictors for anxiety
changes. Importantly, adding the individual connectivity strength
between LC and amygdala during the upregulation response
(model 6) lead to another increase in adjusted explained variance
(another 50%, resulting in approximately 12 times the variance
explained by the base-model) and above-chance out-of-sample
predictions (p < 0.001, 58.7%, Fig. 8b). These results thus establish
both LC responsivity (p= 0.038) and LC-amygdala-connectivity
(p < 0.001) during upregulation as important biological predictors
for anxiety symptom changes and thus stress resilience. The
usefulness of these variables was further underscored by the
fact that the most parsimonious model contained LC-connectivity
(p < 0.001), LC (p= 0.025), pupil (p= 0.053) and the behavioral
CSE (p < 0.031). This model delivered the highest adjusted
explained variance of 51.8% and predicted symptom severity
change out-of sample (p < 0.001, 59.2%, Fig. 8c).
For depression symptom severity changes, the LC conflict
response was also the most reliable predictor, even though the
base model already explained 23.3% adjusted variance, primarily
due to the PHQ-depression score at T0 (p= 0.0002, model 1, see
supplemental results for details). On top of this established
measure, the individual LC upregulation response was the only
biological marker that reliably related to depression symptom
changes (p= 0.046), even when controlling for behavioral CSE (p
= 0.88), pupil distance (p= 0.14), or LC-connectivity (p= 0.74).
The LC upregulation regressor added 4% of the adjusted variance
(27.1%, model 3) to that achieved by the base model; this was
similar to the variance explained by the full model including all
parameters (27.6%, model 6, with 64.4% out-of-sample accuracy
Fig. 9b). LC (p= 0.039) and PHQ score at T0 (p= 0.0009) were
also the only two markers identified by the most parsimonious
model, which explained 30.2% adjusted variance and significantly
predicted mean symptom severity changes out-of-sample (p <
0.001, 67.7% accuracy, Fig. 9c). These results were also robust to
non-prospective factors such as the number and severity of
adverse events experienced during the internship (please see
supplemental information for details and Supplemental Table S4
for comprehensive statistics).
Additional receiver operating characteristic (ROC) and AUC
plots (Figs. 8, 9 and S12–S14) further facilitate the comparison
between anxiety and depression predictions as well as between
Fig. 7 Conflict-related pupil response relates to LC responsivity and
stress resilience. a Evidence for carry-over effects of LC-NE responses as
measured by pupil dilation: The stronger the pupil dilation before
incongruent trials, the lower the pupil dilation elicited by this incongruent
trial (R=−0.52, p= 0.00014); this effect is specific to incongruent trials.
b The degree of pre-trial pupil-dilation difference (CI > II) correlates with
LC-NE upregulation responses (CI-II), consistent with a noradrenergic
mechanism that drives upregulation of resources to meet current trial
conflict demands (R=−0.30, p= 0.038). c, d The larger the individual
impact on pupil dilation from previous to current incongruent trials (pupil
dilation distance between current CI-II and previous trial CI-II), the more
increases are observed for (c) anxiety (R= 0.36, p= 0.013) and (d)
depression (R= 0.30, p= 0.04) symptoms (for simplicity we averaged
symptom changes between 3 and 6 months). a–d Pearson correlation.
e, f The pupil dilation distance between current CI-II and previous trial CI-II
predicts mean symptom changes due to real-world stress reliably out-of-
sample for depression (f, p < 0.001), but only marginally for anxiety (e, p=
0.09). Prediction analyses were based on a leave-two-subject-out cross-
validation procedure; their significance was tested using a permutation test
with 1000 permutations for each possible left out pair combination. Source
data are provided as a Source Data file.
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different predictors. For instance, for prediction of both anxiety
and depression, these plots show that the predictive power of LC-
NE (Figs. 8g, 9g) exceeds that of pupil signals (Figs. 8i, 9i) as well as
of LC-amygdala connectivity (Figs. 8h, 9h). While the predictive
power of LC-NE for anxiety is fairly moderate (Fig. 8g), it clearly
outperforms anxiety predictions from behavioral measures
(Fig. 8d). Furthermore, LC-amygdala connectivity predictions for
anxiety (Fig. 8h) are clearly stronger than for depression (Fig. 9h),
while pupil dilation predictions for depression (Fig. 9i) outperform
the ones for anxiety (Fig. 8i). Please see Supplemental Figs. S12–
S14 for ROC plots and AUC quantification for all models tested.
Taken together, both comprehensive regression analyses for
anxiety and depression symptom change establish that noradre-
nergic LC responsivity constitutes a strong and reliable marker for
prospectively predicting individual stress resilience in response to
real-world stressors.
Discussion
Stress resilience is conceptualized as adaptive, and presumably
active, process rather than simply the absence of pathological
responses26,107. This key insight has recently led to a paradigm
shift in resilience research away from disease-centered perspec-
tives towards a health-focused agenda50,108–110. Despite growing
interest in stress resilience in at-risk populations6,7,111,112, it has
so far been difficult to implement resilience trainings and monitor
resilience indicators due to a lack of reliable indices and accurate
assessment tools113. In particular, the precision of current
assessments of stress resilience is compromised by the problems
associated with meeting four methodological challenges.
First, individual assessments, particularly neurobiological
assessments, of stress susceptibility have rarely been conducted
before potentially traumatic stressors are experienced. It has thus
been difficult to identify factors that genuinely predispose indi-
viduals to be resilient when they subsequently face adverse events.
Identifying such predictors and potential resilience mechanisms is
essential for the development of procedures to prevent the onset
of stress-related psychopathology, such as anxiety and
depression52,113, in addition to informing potential treatments for
when stress-related pathology has manifested. Second, potential
resilience assessments have rarely been validated against the
impact of real-world stressors. This is a crucial drawback, as
Fig. 8 Comprehensive model comparison for predicting anxiety symptom change. a–c Prediction analyses were based on a leave-two-subject-out cross-
validation procedure and their significance was tested using a permutation test with 1000 permutations for each possible left-out pair combination. Light
gray bars show the distribution of prediction accuracies that can be expected by chance (shuffled labels, see methods sections for details). Dashed vertical
lines represent the 5th and 95th percentile of this distribution. Vertical black line indicates the obtained out-of sample accuracy. a A base-model containing
scores from anxiety and pretrauma surveys does not predict the individual mean changes in anxiety symptom severity due to real-world stress above
chance (out-of-sample accuracy= 51.86%, p= 0.234, R2= 0.08, adjusted R2= 0.037). b Using a full model that additionally contains behavioral-, neural-
and pupil data predicts mean anxiety increases significantly above chance (out-of-sample accuracy= 58.7%, p < 0.001, R2= 0.57, adjusted R2= 0.50).
Compared to the base-model, the full model increases the explained variance by 49% and the adjusted explained variance by 47%. Locus coeruleus
contribution is significant (p= 0.038). c The optimal model, established using a stepwise-regression procedure (Methods), shows similar prediction
improvements (out-of-sample accuracy= 59.2%, p < 0.001, R2= 0.56, adjusted R2= 0.52) but comprises only four parameters: locus coeruleus
upregulation response (p= 0.025), behavioral congruency-sequence effect (CSE, p= 0.031), pupil (p= 0.05) and LC-NE-Amygdala coupling during the
upregulation response (p < 0.001). Compared to the base-model, this sparse model predicts 49% more of the variance and also 48% more of the adjusted
variance. d–i Receiver operating characteristic (ROC) plots and area under the curve (AUC) for different combinations of measures predicting anxiety:
(d) Base-model, (e) Full-model, (f) Optimal model, (g) LC-only, (h) LC-Amygdala only, (i) pupil only. Please see Supplemental Table S7 for additional
models, full details on single regressor contributions and model comparison. Source data are provided as a Source Data file.
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previous stress experiments have primarily focused on the acute
stress response without any consequences for real-life
behavior114,115. Furthermore, the commonly employed labora-
tory stressors have multiple shortcomings—such as limited
exposure time and low intensity—and thus lack real-world
validity or predictability56. Third, resilience predictors have only
rarely been cross-validated against independent data81. Fourth,
only few predictors of resilience are grounded in experimentally-
measured psychological and physiological mechanisms. This
appears essential because assessments only based on self-report
often have limited reliability and can be susceptible to self-
reporting bias113.
The current study met these challenges by identifying and
cross-validating prospective biomarkers for resilience that fit
these requirements. We show that greater activation of the LC-
NE system during the upregulation response is associated with
elevated symptoms of depression and anxiety after real-world
stress, whereas lower conflict activation of the LC-NE system
predicts resilience, i.e., the absence of future elevated symptoms.
Furthermore, simultaneously-acquired measures of pupil-dila-
tion, potentially associated with LC-NE firing53, corroborate LC-
responsivity as a reliable predictor for stress-related psycho-
pathology and provide insights into the noradrenergic basis of
conflict generation and adaptation.
Here we relate functional responses in the LC-NE system
prospectively to stress resilience in humans. This link is not
unexpected since the LC-NE system is a major component of the
centrally-mediated fight-or-flight response and strongly activates
as a result of various environmental stressors, including social and
predator stress in rodents and non-human primates22,24,80,116–120.
In addition to stress reactivity, the LC-NE system has been
implicated in a large number of other physiological functions
including arousal, memory, cognition, pain processing, and gen-
eral behavioral flexibility, all of which may be mediated by its
innervation of the entire neo-cortex through long-range nora-
drenergic projections24,121–125. Responsivity of LC-NE may thus
play a prominent role in determining arousal state and environ-
mental reactivity, making the LC-NE system an ideal neural hub
for the facilitation of adaptive behavioral responses to stressors.
Dysfunctions or hyperresponsiveness of the LC-NE system have
indeed been implicated as a key factor for the development of a
variety of pathophysiologic conditions, such as anorexia nervosa,
obesity, PTSD, and related affective disorders in humans25,46.
Medical professionals are exposed to stress in their jobs76,77,79,
requiring them to switch their own state to fit these contexts and to
respond in adequate ways. In such high-stress environments, it is
vital to keep arousal levels at bay to ensure patients’ well-being and
optimal outcomes126. The LC-NE has been associated with an
Fig. 9 Comprehensive model comparison for predicting depression-symptom change. a–c Prediction analyses were based on a leave-two-subject-out
cross-validation procedure and their significance was tested using a permutation test with 1,000 permutations for each possible left-out pair combination.
a The base-model predicts mean depression symptom increases significantly above chance (out-of-sample accuracy= 67.38%, p < 0.001, R2= 0.27
adjusted R2= 0.23). The PHQ-survey score is already a significant predictor for depression symptom severity changes (p= 0.0002). b The full model
containing additional behavioral-, neural- and pupil data predicts mean depression increases significantly above chance (out-of-sample accuracy=
64.36%, p < 0.001, R2= 0.37, adjusted R2= 0.28) and increases the explained variance by 11% and the adjusted explained variance by 4.3%. c The optimal
model has similar prediction improvements as the full model (out-of-sample accuracy= 67.7%, p < 0.001, R2= 0.33, adjusted R2= 0.30) but contains only
two parameters: locus coeruleus upregulation response (p= 0.039) and the PHQ-depression survey (p= 0.0009). Compared to the base-model, this
sparse model predicts 10% more of the variance and also 10% of the adjusted variance. d–i Receiver operating characteristic (ROC) plots and area under
the curve (AUC) for different combinations of measures predicting depression: (d) Base-model, (e) Full-model, (f) Optimal model, (g) LC-only, (h) LC-
Amygdala only, (i) pupil only. Please see Supplemental Table S8 for additional models, full details on single regressor contributions and model comparison.
Source data are provided as a Source Data file.
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orienting and reorienting function that detects salient or beha-
viorally relevant stimuli and interrupts and resets ongoing
activity127–129. A well-functioning LC-NE system that is not
strongly taxed by this continuous challenge will have the capacity
to optimally switch between behavioral relevant strategies in
response to the changing demands. However, a maladaptive
hyperactive LC-NE system may induce excessive arousal associated
with unneccessary strategy switches or switches to task-irrelevant
strategies; this in turn can violate own expectations as well as other
peoples’ and thereby cause further arousal and uncertainty that
triggers anxiety and fear. This self-perpetuating cycle has been
associated with increased LC-NE firing65,130. In fact, well-adapted
behavioral and regulatory flexibility has recently been identified as
a crucial psychological factor modulating anxiety susceptibility131,
which may in part be biologically predetermined by individual LC-
NE responsitity, as we show here.
Anatomical data in rats identified monosynaptic projections
from the central nucleus of the amygdala to terminate in the
LC119. More recent work in mice strongly implicated activity of
the LC-NE system with stress-induced anxiety, by showing that
selective inhibition of LC-NE neurons during stress prevents
subsequent anxiety-like behavior30. In addition, it was demon-
strated that photostimulation of LC projections to the basolateral
amygdala releases NE. Moreover, this photostimulation evokes
downstream modulation of neuronal activity in the amygdala,
which resulted in anxiety-like and aversive behavioral responses
in mice40. No such relationship has been demonstrated in
humans. So far, human functional imaging studies associated the
amygdala with emotional intensity as well as the perception of
fear and threat36–39. Here we show that individual differences in
functional coupling between LC-NE and amygdala prior to a real-
world stressor is associated with the subsequent development of
anxiety- but also depression-symptoms in humans, similar to
documented mechanisms in mice30,40,119. This suggests a putative
pathway by which LC-NE hypereactivity may lead to the emer-
gence of psychopathology: Perhaps excessive LC-NE influences
on the amygdala may induce elevated levels of threat perception
or emotional intensity, which in turn lead to enhanced anxiety
and potentially related depression symptoms? Thus, our data
imply not only LC-NE hyper-responsivity but also LC-NE cou-
pling to the amygdala as a potential focus for intervention in
preventing stress-related affective disorders.
Our results have potential implications for clinical and pre-
vention science. Providing successful replication and extension to
other samples, the LC-NE upregulation response, LC-con-
nectivity, and potentially pupil dilation could be indexed to
predict individual levels of resilience in stress-affected popula-
tions (e.g., policemen, soldiers, firemen, etc.). This may ensure
that individuals at risk (i.e., high LC-NE responsivity predicting
critical levels of symptom severity changes) are offered inter-
vention or additional prevention approaches. It is conceivable
that targeted change could be implemented by means of training
functional response regulation or by neurofeedback in combina-
tion with real-time fMRI targeting the LC-NE132. Indeed, pro-
mising findings have recently indicated that emotion regulation
can be trained via neurofeedback133 and that connectivity mea-
sures are particularly suitable for this methodology134,135. Our
finding that enhanced LC-amygdala functional coupling strongly
relates to elevated anxiety symptom changes renders this con-
nectivity measure an encouraging target for future prevention and
intervention efforts.
Our study is not without limitations. Three major points should
be taken into consideration. First, optimal functional imaging of
the brainstem, and in particular the LC, is difficult due to the small
size of the nuclei, their proximity to the ventricles, and inherently
low signal-to-noise ratio in the brainstem. Identification of LC-NE
activity may thus benefit from more specialized data acquisition
techniques than those applied here85–87,136,137. For instance, on
the acquisition side, one may obtain high-field imaging for
superior signal-to-noise ratio, high resolution T2-weighted ana-
tomical imaging for accurate brainstem registration to standard
space, neuromelanin-sensitive imaging for localization and dis-
sociation of individual participants’ LC from other brainstem
nuclei. In addition, partial functional brain coverage could achieve
particularly small (submillimeter) voxel resolution with high tSNR
to avoid partial voluming effects and to counteract pulsating
artifacts in the CSF and adjacent 4th ventricle. Pulsation could be
quantified and mitigated with continuously recorded electro-
cardiogram. While future studies could use such specialized
technology to focus on the LC with more certainty, in the present
study, we applied more routine MR imaging protocols that can be
replicated in numerous research settings worldwide. However,
local specificity and physiological noise reduction can also be
optimized via specialized analysis techniques, which we did apply
here. For instance, we controlled for physiological noise by
including principle components of the time-course in the CSF as
nuisance regressors in the GLM analysis138. Moreover, to enhance
the regional specificity of our results, we also analyzed activity
from LC-adjacent brainstem nuclei and by repeating our initial
analyses for unsmoothed data from a smaller LC mask (1SD vs.
2SD). Applying all these techniques to our data in fact enhanced
the predictive accuracy of LC activity for symptom changes and
showed that data from other brainstem nuclei do not allow this
prediction. Thus, despite our use of more standard imaging pro-
tocols, our data provide evidence that specifically LC activation in
response to emotional conflict predicts symptom changes in
response to real-life stress (for detailed description of the applied
methods and results please see supplemental methods, Tables S6–
S8 and Figs. S4–S8).
Second, even though pupil dilation has primarily been asso-
ciated with LC-firing and the noradrenergic system, recent evi-
dence has identified also a cholinergic component54,139. Pupil
dilation is thus hardly a specific noradrenergic marker but may
reflect activity in multiple neuro-modulatory systems simulta-
neously. Dissociating the contributions of various neuro-
modulatory systems to pupil dilation should be the focus of
future human imaging studies. Nevertheless, because current eye-
tracker systems can be portable, easy-to-use and inexpensive, our
data suggest that pupil dilation can be very useful as a diagnostic-,
monitoring- and treatment-tool not only for stress-related
psychopathology71,140–142 but also for studying the aging popu-
lation and children.
Third, we investigated a modestly-sized medical student sample.
While this sample is representative for the student population at
Swiss medical schools, our results may not easily be generalizable
to other populations across the world. For example, depression
and anxiety levels were generally low in our sample, lower than in
some other studies79, hence indicating potential differences in
selection or stress exposure. Working hours, in particular, tend to
be lower in the Swiss medical internship system compared to the
US143, leading to potentially milder levels of stress exposure and
symptom levels in the current cohort compared to medical resi-
dents in the US (see Supplemental Table S2–S3). In spite of such
differences, there is clear evidence that Swiss medical internships
are associated with occupational stress and vulnerability to psy-
chopathology, as evidenced by a worsening of physical and psy-
chological well-being and life satisfaction after the first year of
internship/residency compared to before144 and by the presence of
relevant anxiety symptoms in 30% of residence physicians145.
Furthermore, while maintenance of mental health and the
absence or low levels of depression and anxiety can be con-
ceptualized as resilient responding, resilience is potentially more
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complex. Future studies may benefit from including further
components of this concept, for example, variability over time
and individual coping strategies, as well as investigating trajec-
tories of change using latent growth mixture models146. Finally, it
would be useful to repeatedly assess LC-NE responses to test
whether those who are resilient (i.e., who remain healthy despite
exposure to adversity) indeed show lower LC responsivity not just
prior to but also during the real-life stressor.
In conclusion, our human prospective study of resilient
responding identified laboratory measures of neurobiological
mechanisms (LC-NE activation and connectivity during upre-
gulation) that relate to future adaptive mental health outcome
and resilience in response to real-life stressors. Our findings help
to elucidate the neural basis of stress resilience in humans, inform
prevention and intervention science and hold considerable
potential for better diagnosis and treatment of stress-related
psychopathology.
Methods
Participants. We recruited medical students prior to their first medical internship.
From the cohort of 200 students, 96 expressed an interest to participate. Following
standard exclusion criteria (fMRI safety, psychopathology or attendance failure, see
Supplement for details), the final sample consisted of 48 medical students (n= 28
women, mean age= 24 years, SD= 1.99). Participation was voluntary, and parti-
cipants provided written informed consent.
Study design and procedure. The study was carried out over a period of
6 months. Just before commencing their internship (t0), participants took part in
an fMRI session that included the conflict adaptation task and several ques-
tionnaires. Three (t1) and 6 months (t2) after starting their internship, participants
completed questionnaires assessing wellbeing, depression, anxiety and other vari-
ables (see below). After the study, participants were debriefed and compensated for
their participation (US$ 35 per hour). All procedures were approved by the Can-
tonal Ethics Committee of Zurich (KEK).
Self-report questionnaires. At baseline, participants completed questionnaires
about demographic and clinical information (Supplemental Table S5) as well as an
adapted version of the Trauma Checklist derived from the Posttraumatic Diag-
nostic Scale (PDS)147, which was used to index the number of previously experi-
enced potentially traumatic events (pretrauma-score) prior to the internship.
Anxiety symptoms148 were assessed with the State-Trait Anxiety Inventory
(STAI)149 and depression symptoms with the Patient Health Questionnaire
(PHQ-9)150. Both anxiety and depression levels were indexed at all three time
points (t0, t1, t2) to investigate potential changes in symptom-severity across time
(see Supplement for details on questionaires and internal consistency). Change
scores were computed by subtracting baseline at t0 from mid-internship
questionnaire scores (t1 and t2), thus indexing change in anxiety and depression
from baseline to mid-internship. These indices were then regressed on
upregulation responses in the LC-NE arousal system (see below). As expected, we
found considerable interindividual variation in depression and anxiety symptoms
across participants, hence indicating different susceptibility to stress and resilience.
Non-prospective data were acquired to quantify the exposure to stressful
experiences during the internship by asking subjects whether they had experienced
stressful events at work by indicating exposure to patient death, invasive treatment,
attending to grieving relatives, agitated relatives, grave treatment errors, or other
events (detailed description in the Supplemental methods section).
Data analysis
Behavioral analyses. To interrogate behavioral conflict responding, we used multiple
linear (RT) and logistic (accuracy) regressions onto the following trial-wise predictor
variables: current trial congruency, previous trial congruency, the interaction of
current and previous trial congruency, and current-trial emotional valence. Each
regression model was fitted independently for each subject; the resulting parameter
estimates were standardized and their deviance from 0 was estimated with a two-
sided t test. Statistical behavioral analyses were performed using the glmfit-, ttest-,
and corr-functions implemented in the statistics toolbox in matlab version 2017a
(see Supplement for further information).
fMRI data analysis. We used standard fMRI data-analysis procedures and esti-
mated a general linear model (GLM) with SPM8 (Wellcome Trust Centre for
Neuroimaging) to identify regions associated with upregulation processes, defined
as the response difference between CI and II trials. This contrast was used to test
whether upregultion responses in the LC-NE arousal system predict individual
stress resilience. Eye movements and blinks were added as nuisance regressors151.
The GLM regressed the blood oxygen level-dependent (BOLD) signal in each voxel
on these regressors and a set of hyperparameters modeling MR image auto-
correlations with a first-order autoregressive model (see Supplement for full
details).
Psychophysiological analysis (PPI). We added to our GLM design matrix the BOLD
time series extracted from a 5 mm sphere centered on the subject-specific LC peak
in the CI > II contrast, determined by LOSO (see below). We also added two
interaction terms corresponding to the interactions of the extracted BOLD time-
course and the CI and II regressors. The difference in functional coupling during
upregulation (CI > II) was then assessed in the amygdala and also utilized as stress-
resilience predictor.
Leave-one-subject-out (LOSO) procedure. This method derives an unbiased pre-
diction score, as each participant’s data is extracted from a sphere (5 mm radius)
around the group-peak coordinate in the data of all other participants, excluding
the data from the current participant90,91. For each LOSO analysis, the peak was
determined by the CI > II statistical contrast map within the region under study.
Leave-two-subject-out (LTSO) procedure. This method allows us to test how pre-
cisely a given model predicts which out of two randomly-drawn participants is
more resilient, i.e., will develop lower symptom severity changes. We first generated
all possible combinations of training- and test-sets: In each training set, we esti-
mated a given model on the data of N-2 participants and predicted the symptom
severity change for the two left-out participants. We then compared the predicted
to the true change score for each of the 2256 possible left-out pairs and determined
the prediction accuracy by calculating the percent correct predictions across all left-
out pair combinations. In order to quantify how often this accuracy would occur by
chance, we generated a null distribution of prediction accuracies. To this end, we
repeated the model fit and prediction on shuffled symptom severity labels for each
left-out pair 1000 times and calculated the obtained accuracy for each pair com-
bination. The reported p-value represents the probability that the observed accu-
racy (based on unshuffled data) occurred by chance. Specifically, the 95th
percentile of the null distribution is the lower accuracy bound above which all
accuracies exceed a 5% probability of having occurred by chance.
Eye-tracking and pupil dilation. Subjects’ fixation patterns and pupil size were
recorded at 250 Hz with an MR-compatible infrared EyeLink 1000 eye-tracker
system (SR Research Ltd.) and the Eyelink toolbox version 1.6 (https://github.com/
uzh/edf-converter). Epochs of pupil signal loss were corrected via linear inter-
polation. Pupil time series were high-pass-filtered with a low cut-off of 0.05 Hz
followed by a low-pass-filter with a high cut-off of 4 Hz. Each run-wise pupil time
series was z-scored. Trial-wise pupil data were extracted ±5 s from stimulus onset
and averaged per subject according to conditions of interest (congruent, incon-
gruent, CI, II, CC, IC, Fig. 6a,c,e). Relevant contrasts (incongruent > congruent, CI
> II, IC > CC) were computed for each participant. Time periods of significant
difference from zero (p < 0.05) for pre-trial and current-trial pupil across all par-
ticipants and contrasts were identified via one-sample t tests versus zero (Fig. 6b,d,
f) and corrected for multiple comparisons using a cluster-based permutation test
(Supplemental Methods). For each participant, the CI > II pupil dilation within the
significant time intervals (gray shading Fig. 6f) was averaged to derive one score per
subject for pre-trial (−3044 to −1222ms) and current-trial (1530 to 4862 ms) pupil
dilation difference.
To assess the impact of pre-trial pupil dilation difference onto current-trial
difference, and to estimate its relationship with LC-NE conflict upregulation, pre-
trial pupil difference was correlated with current-trial pupil difference and LC-NE
upregulation (CI > II) (Fig. 7a,b). To derive a subject-specific pupil dilation
measure that quantifies the noradrenergic impact of pre-trial pupil difference onto
current-trial pupil difference, a distance score was computed (Pupil dilation
distance, PDD= (CI-II)Current – (CI-II)Pre, within above-defined time periods).
This physiological marker used as predictor of mean symptom severity changes in
multiple regressions and out-of-sample procedures (LTSO).
Quantifying physiological markers in stress resilience prediction. In order to
quantify whether the identified physiological markers are useful for predicting
prospective mean symptom severity change over and above the current gold
standard for such predictions, we first assessed the predictive power of a base
model (GLM, matlab function fitglm) containing only the scores from the
traditionally used clinical resources, i.e.: respective symptom severity survey at T0
and preTrauma-survey (model 1 in Supplemental Table S7 for anxiety and
Table S8 for depression). We obtained several measures of model quality, such as
variance explained, adjusted variance explained, Akaike Information Criterion
(AIC), Bayesian Information Criterion (BIC). We also assessed whether adding our
behavioral and physiological variables of interest (classic RT congruency-sequence
effect (CSE) score, LC-responsivity, Pupil-dilation-distance (PDD), and LC-
Amygdala functional coupling) to increasingly complex models significantly added
to the model fit and/or improve goodness-of-fit measures (models 2-6 in Tables S7
and S8). Moreover, we quantified whether each model predicted mean symptom
severity changes significantly above chance in an out-of-sample fashion using
LTSO (see above). In addition, we quantified how much more variance and
adjusted variance can be explained over and above the base model. Finally, we used
a stepwise-regression approach to obtain the most parsimonious model that trades-
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off model complexity with goodness-of-fit (model 7, implemented as stepwiseglm
in matlab). The procedure starts by adding predictor variables to the constant
model, as long as the value for the test statistic, deviance (the differences in the
deviances between the models, tested via chi-squared test), is less than the default
threshold value 0.05. If this criterion is not met the current term is removed. This
procedure continues until all terms have been tested. Stepwise-regression balances
the cost of poor fit due to too few model terms, with the chance of overfitting
caused by too many model terms.
Optimizing brainstem signal analysis. Imaging the brainstem, and in particular the
LC, is difficult due to the small size of the nuclei involved, their proximity to the
ventricles, and inherently low signal-to-noise ratio in the brainstem. We conducted
several analyses addressing physiological noise correction, weighted average data
extraction, local specificity for the locus coeruleus, by comparing anxiety and
depression symptom change predictions based on liberal and conservative LC
masks (LC-1SD and LC-2SD) and several other brainstem nuclei.
We controlled for physiological noise with nuisance regressors that reflected the
time-course within the cerebrospinal fluid (CSF)138. The CSF mask was generated
for each individual by the non-linear unified segment procedure in SPM12 (see
above). Time series were extracted for all voxels included in this mask and were
submitted to principle component analysis using the matlab function pca.m
included in the statistics toolbox (MATLAB, The MathWorks, Inc., Natick,
Massachusetts, U.S., version 2017a). The first five principal components for each
participant were used as nuisance regressors in the GLM analysis, alongside 6
motion regressors. Supplemental Fig. S7 provides a visualization for the first 2
participants and Supplemental Table S6 reports the improved statistical results for
predicting symptom severity changes following the application of this technique.
We ensured predictive relevance and local specificity for the locus coeruleus by
comparing anxiety and depression symptom change predictions based on both LC
masks (1SD and 2SD) and several other brainstem nuclei. In addition, we
employed a weighted-average data extraction that weighed every voxel’s activity
with the probability of membership in the ROI assigned to each voxel. These
probabilistic maps included the main brainstem nuclei in the vicinity of the LC, i.e.:
medial raphe nucleus (MR), dorsal raphe nucleus (DR), and ventral tegmental area
(VTA) provided by the Harvard Ascending Arousal atlas available at https://www.
martinos.org/resources/aan-atlas. We also compared LC prediction power with the
substantia nigra (SN), available at https://www.nitrc.org/projects/atag/ and the
amygdala (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Atlases). In addition, we repeated all
GLMs also for unsmoothed data, since the 6 mm smoothing kernel we applied may
have smeared the activity between brainstem nuclei as well as with adjacent CSF.
Please note that all LC-specific results reported in the main text are based on a
weighted average of LC-1SD mask voxels extracted from the physiological-noise-
corrected, unsmoothed fMRI data. Applying these optimized brainstem signal
analysis techniques substantially enhanced the data quality and statistical
significance of our results. Thus, even though our use of a more standard imaging
protocol with normal rather than high spatial resolution requires the appropriate
caution when assigning activations to the small LC, our extensive set of control
analyses substantiated our conclusions that anxiety and depression symptom
severity are best predicted by the responsivity of the human LC-NE arousal system.
Data visualization. MRIcroGL (https://www.mccauslandcenter.sc.edu/mricrogl/
home/) was used for brain visualizations.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data supporting the findings of this study are available at https://github.com/mgrues/
LC_Stress_GitHubRepository (https://doi.org/10.5281/zenodo.4298505). A reporting
summary for this Article is available as a Supplementary Information file. Source data are
provided with this paper.
Code availability
Matlab Code is available at https://github.com/mgrues/LC_Stress_GitHubRepository
(https://doi.org/10.5281/zenodo.4298505).
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